Autopsy report · NCT04107714
Starting the Conversation
Cause of deathSlow enrollment
“The study was terminated due to a small number of study participants.”
Life of this trial
- Ran for about 1 year 7 months before it stopped.
- 5 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- University of Ulm
- Sponsor type
- University, hospital or other
- Conditions
- Stigma of Parents of Children With Mental Illness
- Interventions
- STC
- Participants
- 5
- Sites
- 1
- Countries
- Germany
Trials that died the same way
- Phase 2 Study of OBP-301 (Telomelysin™) in Combination With Pembrolizumab and SBRT in Patients With HNSCC With Inoperable, Recurrent or Progressive Disease
“This study was terminated due to low participant enrollment.” - The Role of Splinting in Fingertip Injuries
“Very few subjects were enrolled. Therefore, the study was terminated.” - Leronlimab (PRO 140) Combined With Carboplatin in Patients With Cytokine Chemokine Receptor 5 Positive (CCR5+) mTNBC
“Study terminated prematurely due to business reasons. Participants are no longer examined or receiving intervention.” - A Study of Duvelisib in Combination With Pembrolizumab in Head and Neck Cancer
“The study was terminated due to low enrollment.” - Dilute Bleach Baths in Pediatric Patients With Atopic Dermatitis
“the study was terminated due to participant drop out”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.